The FDA has accepted the supplemental Biologics License Application (BLA) for ropeginterferon alfa-2b-njft (Besremi), a ...

Legislation which will overhaul the judicial review process has been published by the Minister for Justice. Jim O'Callaghan pledged that it would result in greater transparency and a more streamlined ...

BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative ...

Good morning, everyone. Thanks for being here today. My name is Ranveer Gathwala. I'm a Vice President in the Healthcare Investment Banking Group at JPMorgan. It is a great pleasure that we have ...

The small lift in Vertex Pharmaceuticals' fair value estimate to US$496.16 per share, alongside a slightly higher discount rate and a touch stronger long range revenue growth assumption, reflects how ...